Spot Trading’s SELLAS Life Sciences SLS Stock Holding History

Spot Trading’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5	Closed	-$4K	–	3351
2017 Q2	$4K	Hold	5	–	–	﹤0.01%	3103
2017 Q1	$5K	Buy	+5	New	+$8.28K	﹤0.01%	2799

Other funds holding SLS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Spot Trading's SLS Position: Q3 2017 in Review

Spot Trading sold out of SELLAS Life Sciences (SLS) in Q3 2017, closing a stake of 3 shares — an estimated $3K sold.

Spot Trading first reported a position in SLS in Q1 2017 and held it in 2 quarters. The position peaked at $3K in Q2 2017. 28 funds tracked by Wall St. Rank hold SLS as of Q3 2017.

Spot Trading reported no remaining SELLAS Life Sciences position as of Q3 2017 after selling out during the quarter.
Spot Trading sold 3 SELLAS Life Sciences shares in Q3 2017, an estimated $3K.
Spot Trading first reported a position in SELLAS Life Sciences in Q1 2017 and held it in 2 quarters.
Spot Trading's SELLAS Life Sciences position peaked at $3K in Q2 2017.
28 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.